New drugs and generics will enter the arthritis treatment market with a full of medications that reduced the heartburn side effect
It is known that the nonsteroidal anti-inflammatory drug (NSAIDs) market is getting hotter as many arthritis treatments that reduced gastrointestinal side effects enter.
As the Pfizer’s COX-2 inhibitor ‘Celebrex’ is leading the market, new drugs and generics is about to challenge it.
Complexes ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
